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Advances in surgical techniques and laparoscopic instruments have resulted in the development of laparoscopic pan-
creatic surgery. Total pancreaticoduodenectomy is performed for treating benign and borderline pancreatic disease 
involving the whole pancreas. Here, we report a case of metastatic renal cell carcinoma in the pancreas, treated by 
laparoscopic pylorus-preserving total pancreaticoduodenectomy. A 59-year-old woman was diagnosed with metastatic 
renal cell carcinoma. Multiple metastatic lesions were found on routine follow-up. She had a history of radical video-as-
sisted right-nephrectomy for renal cell carcinoma (conventional type, pT1) in November 2003, without any recurrence. 
However, in 2014, a routine health checkup revealed multiple enhancing lesions throughout the pancreas. Positron 
emission tomography showed a suspicious 4-cm lesion in her left thyroid. Laparoscopic pylorus-preserving total pan-
creaticoduodenectomy with splenectomy was performed, along with simultaneous left total thyroidectomy with central 
compartment node dissection for metastatic renal cell carcinomas. The total operation time was 441 min, with an esti-
mated blood loss of 150 ml; no transfusion was administered. Her hospital stay was 12 days. The histopath report 
confirmed metastatic renal cell carcinoma in the pancreas and left thyroid. Based on literature reviews, we further 
tried to estimate the oncologic outcome of total pancreatectomy in multiple pancreatic metastasis of renal cell 
carcinoma. Laparoscopic pylorus-preserving total pancreaticoduodenectomy is feasible and safe, even in cases of 
metastatic renal cell carcinoma. (Ann Hepatobiliary Pancreat Surg 2017;21:96-100)
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INTRODUCTION
Pancreatic metastases from other primary cancers are 
uncommon, accounting for less than 5% of pancreatic 
cancers. Primary cancers reported to metastasize to the 
pancreas include renal cell carcinoma (RCC), lung cancer, 
colon cancer, and breast cancer; among these, RCC is the 
most frequent primary cancer.1 As pancreatic metastases 
of RCC are usually slow growing, with tumor-free inter-
vals ＞10 years, they are asymptomatic in more than 50% 
of cases and are usually incidental findings during 
long-term follow-ups.2 Although uncommon, when the 
primary cancer metastasizes only to the pancreas, the pan-
creatic resection of the isolated metastasis is proven to im-
prove long-term patient survival.3
Here, we report what we believe to be the first case 
of laparoscopic total pancreatectomy for metastatic cancer 
from RCC, which occurred 11 years after initial neph-
rectomy for RCC. In addition, we review the literatures 
to provide rationales and oncologic insight for total pan-
createctomy in multiple pancreatic metastasis of RCC.
CASE
Patient presentation: A 59-year-old asymptomatic 
woman was admitted to our pancreaticobiliary surgery de-
partment, for multiple pancreatic lesions incidentally 
found during a routine follow-up. She had a prior history 
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Fig. 1. Preoperative computed 
tomography scans and micro-
scopy images of a metastatic re-
nal cell carcinoma (RCC) in the
pancreas and thyroid. Multiple, 
variable-sized (range, 0.7 cm-2 
cm) contrast-enhancing nodules 
are visible in the pancreas head
(A), body and tail (B). An 18-F
fluorodeoxyglucose (FDG) posi-
tron emission tomography scan 
shows mild FDG uptake in the 
left thyroid (C), and a neck ul-
trasonography scan reveals an 
approximately 4-cm solid hypo-
echoic mass in the left thyroid 
gland (D). Metastatic RCC was 
confirmed in the pancreas (E-1), 
and thyroid (E-2). Note the 
characteristic appearance of 
RCC with clear cytoplasm ar-
ranged in nests (E-3). T, tumor; 
Pan, pancreas; Thy, thyroid.
of radical right nephrectomy for RCC (conventional type, 
pT1). On a follow-up computed tomography (CT) scan 11 
years after her nephrectomy, multiple pancreatic masses 
suggestive of metastasis from RCC were found, the larg-
est of which were 2.1 cm and 2 cm on the pancreas tail 
and head, respectively (Fig. 1). Positron emission tomog-
raphy (PET) with F-18 fluorodeoxyglucose (18-FDG) re-
vealed multiple pancreatic tumors with minimal FDG up-
take, as well as a left thyroid tumor with similar FDG 
uptake as the pancreatic tumors (Fig. 1C). Fine needle as-
piration biopsy report was consistent with thyroid meta-
stasis from RCC (Fig. 1D).
Operation: Laparoscopic total pancreatectomy combines 
laparoscopic pylorus-preserving pancreaticoduodenectomy 
and laparoscopic subtotal distal pancreatectomy with 
splenectomy.4,5 Left total thyroidectomy was performed 
through a 6-cm transverse skin incision on the anterior 
neck. The operation lasted 7 hours 21 minutes, with an 
estimated intraoperative blood loss of approximately 150 
ml. Pathologic examination revealed multiple nodules in 
the pancreas, with a maximum size of 1.7 cm×1.1 cm; 
a 3.7-cm nodule was also found in the left thyroid. Both 
these nodules were consistent with RCC metastasis (Fig. 
1E).
Postoperative course: The patient’s postoperative 
recovery was uneventful. She discharged on postoperative 
day 12, without complications. During five months of fol-
low-up, there was no evidence of local recurrence or dis-
tant metastasis.
Literature review
We searched PubMed for reported cases of total pan-
createctomy for multiple pancreatic metastasis of RCC, 
using the keywords “renal cell carcinoma” and “total pan-
createctomy”. A total of 30 case reports written in 
English, describing 50 patients, were identified.1-3,6-17 
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Table 1. Patient demographics and presentation
Organs Number 
Total patients 42
Age, mean and range (years)  64.5 (43-79)
Gender  
  Male:female 18 (42.9%):22 (57.1%)
Time interval between initial nephrectomy and total pancreatectomy, median years (range) 11.06 (1-27)
Renal cell carcinoma metastasis pattern  
  Isolated pancreatic metastasis    28 (58.3%)
  Multi-organ metastasis    20 (41.7%)
Fig. 2. Literature review-based oncologic outcomes of total pancreatectomy for metastatic renal cell carcinoma, showing overall 
disease-specific survival (A), and long-term oncologic outcomes according to time interval (10 years) (B), metastasis pattern 
(C), and maximum tumor size (D).
Patient demographics and presentations are listed in Table 
1. Of note, 28 patients (58.3%) had extrapancreatic mul-
ti-organ metastasis of RCC.11-16
The mean overall disease-specific survival of patients 
who underwent total pancreatectomy for multiple pancre-
atic metastasis of RCC was 84.4 months (95% confidential 
interval [CI]:61.9-106.9) (Fig. 2A). The time interval from 
initial nephrectomy to total pancreatectomy (within 10 
years vs. over 10 years: mean 64.3 months [95% CI: 
48.0-80.6] vs. mean 80.1 [95% CI: 43.1-117.1], p=0.689) 
and metastatic pattern of RCC (pancreas only vs. pan-
creas+others: mean 86.7 months [95% CI: 62.1-111.4] vs. 
53.8 months [95% CI: 47.2-60.6], p=0.316) did not influ-
ence oncologic outcomes (Fig. 2B and C). However, anal-
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ysis revealed that the maximum tumor size influenced the 
oncologic outcome, and tumor size over 3 cm was asso-
ciated with adverse oncologic outcomes in patients with 
total pancreatectomy for multiple pancreatic metastasis 
(p=0.050, Fig. 2D).
DISCUSSION
RCC is the most frequent primary cancer metastasizing 
to the pancreas. Due to the long time interval between pri-
mary RCC and metastasis,9 a long-term and meticulous 
follow-up is required. Literature reviewed by us showed 
that the median time interval between the primary RCC 
resection and pancreatic metastasis was 11 years, ranging 
from 1 to 27 years. In the present case, the multiple pan-
creatic metastases were identified 11 years after the initial 
nephrectomy for RCC. The duration to pancreatic meta-
stasis from initial nephrectomy for RCC was not asso-
ciated with negative oncologic outcomes (Fig. 2B), sug-
gesting that careful follow-up and proper aggressive surgi-
cal approach are important in treating multiple pancreatic 
metastasis of RCC.
We learnt from the current literature review that 
long-term survival of total pancreatectomy in patients with 
multiple pancreatic metastasis of RCC was 84.4 months. 
Compared to oncologic outcomes following surgical re-
section of multiple hepatic metastasis from colorectal can-
cer,18 the survival of patients who underwent total pan-
createctomy for multiple pancreatic metastasis of RCC ap-
pears to be double than those who underwent hepatectomy 
due to liver metastasis of colon cancer, thus providing an 
oncologic rationale to favor aggressive surgical inter-
vention even in multiple pancreatic metastasis. Further 
analysis revealed no significant survival differences with 
other organ involvement in RCC as well as pancreas (Fig. 
2C), supporting our approach of simultaneous thyroi-
dectomy for thyroid metastasis of RCC.
Although kidney cancer was once considered resistant 
to chemotherapy and radiation therapy,19 recent reports 
have shown that tyrosine kinase inhibitor-targeted therapy 
markedly improves the prognosis of patients with meta-
static RCC.20 In our study, metastatic RCC larger than 3 
cm showed poor prognosis for total pancreatectomy (Fig. 
2D).
Our study specifically dealt with several cases of total 
pancreatectomy due to multiple metastasis of RCC. In ad-
dition, the literature review indicated that tumor size less 
than 3 cm has an adverse effect on oncologic outcomes 
in patients with total pancreatectomy for metastatic RCC. 
However, these cases were published from 1972 to 2014 
at various centers, and some important clinicopathological 
variables were not reported. Considering the small patient 
number, a larger, multi-center study is needed to inves-
tigate prognostic factors and rationales of total pan-
createctomy in the relevant patient population.
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